Kevin Weil Launches Warp Sciences to Automate Drug Discovery Labs with Robotics
- Published
- Source
- TechCrunch
Kevin Weil, the former science lead at OpenAI, has founded Warp Sciences, an AI startup dedicated to automating laboratory tasks for drug discovery. The company has successfully raised $215 million at a valuation of $865 million, as announced by Weil on X. This funding round was led by Lightspeed, with additional contributions from IVP, Premji Invest, and Lux Capital.
The significance of Warp Sciences lies in its potential to reshape the drug development landscape by bringing back the labor-intensive synthesis of molecular variations from overseas contractors to the U.S. By utilizing robots trained by human chemists wearing cameras and sensor gloves, the startup aims to mitigate geopolitical supply-chain risks and enhance the efficiency of drug discovery processes.
Looking ahead, Warp Sciences plans to leverage automation to enable continuous operation in wet labs, thereby accelerating the pace of drug discovery. No further timeline was disclosed at the time of publication.
Original report
Former OpenAI science lead launches Warp Science to automate wet labs with robots
TechCrunch · Marina TemkinThis briefing is an independently written summary based on publicly available reporting and is provided for industry information and news discovery. The original report and source publication are credited and linked where applicable. RobotToday does not claim ownership of third-party source material.
Rights concerns? Contact [email protected] with the relevant URL and details. We will review the matter and take appropriate action where warranted.
More related news
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
Related Suppliers
OpenAI
US AI research lab and product company founded 2015; develops GPT, DALL-E, and robotics/embodied AI foundation models targeting physical-world AGI.
Robotae Ltd
Robotae Ltd is a Cambridge, UK robotics and mechatronics consultancy founded in 2014 by Dr Kevin Rathbone, supporting new product development.
Parallel Domain
Parallel Domain is a USA AI & Machine Learning Platform company that generates synthetic sensor data to train autonomous vehicle and robotics perception AI.
CynLr
Bengaluru deep-tech company with visual object intelligence platform enabling robots to pick unknown objects in unstructured environments without pre-training.
Woods Hole Oceanographic Institution
US nonprofit oceanographic research institution founded 1930; operates REMUS, Sentry, and Mesobot AUVs plus ROV Jason for deep-sea science.
Tsubame Lab
Tsubame Lab, a 2025 Tokyo startup from Science Tokyo researchers, automates R&D labs using robotic arms and AMRs run on its open-source Tsubame Studio platform.
Gebr. SCHMID GmbH
German manufacturer of advanced electronics and PCB production equipment; automation systems for electronics, solar, and energy sectors.
AAtek Robo Private Limited
Coimbatore, India authorized DENSO Robotics distributor and system integrator offering industrial automation, lab automation, and Industry 4.0 solutions.
Peak Analysis & Automation
UK laboratory automation integrator formed in 2012 by merger of Process Analysis & Automation (1992) and Peak Robotics Inc (1989); acquired by Grenova in 2025.
Medra
San Francisco startup building Physical AI lab robots that autonomously run drug discovery experiments end-to-end in an autonomous 38,000 sq ft lab facility.
Iktos
Paris-based Iktos pairs generative AI drug design with Iktos Robotics, an autonomous lab running about 100 robotic reactions per day on Chemspeed hardware.
Let's Go Robotics
US-based life sciences laboratory automation specialist offering precision dispensing and liquid handling systems.
Robotics needs a service framework.
RSF defines a common language for robot service capability, lifecycle operations, certification pathways, and service-provider networks.
Join the RobotToday community on LinkedIn
Daily robotics news, in-depth analysis, conference highlights, and discussions with professionals worldwide.